AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026)
AtriCure (ATRC) posted quarterly Total Non-Current Liabilities of $153.0 million for Q2 2026, up 6.83% year-over-year from $143.2 million in Q2 2025, and up 5.51% quarter-over-quarter from $145.0 million in Q1 2026.
AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Total Non-Current Liabilities for 17 consecutive years, with $153.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 6.83% year-over-year to $153.0 million; the TTM figure through Jun 2026 stood at $153.0 million (up 6.83% YoY), while the FY2025 annual figure was $154.9 million, up 5.27% from the prior year.
- Total Non-Current Liabilities rose to $153.0 million in Q2 2026 per ATRC's latest filing, from $145.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $154.9 million in Q4 2025 and bottomed at $120.9 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $138.7 million across 5 years, with a median of $136.0 million in 2023.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities fell 2.2% — and 2023, when it climbed 14.95%.
- AtriCure's Total Non-Current Liabilities stood at $127.5 million in 2022, then increased by 14.95% to $146.5 million in 2023, then rose by 0.42% to $147.1 million in 2024, then increased by 5.27% to $154.9 million in 2025, then dropped by 1.25% to $153.0 million in 2026.
- Business Quant data shows ATRC's Total Non-Current Liabilities at $153.0 million in Q2 2026, $145.0 million in Q1 2026, and $154.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 152.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 152.96 Mn |
| Mar 31, 2026 | 144.98 Mn |
| Dec 31, 2025 | 154.90 Mn |
| Sep 30, 2025 | 151.57 Mn |
| Jun 30, 2025 | 143.19 Mn |
| Mar 31, 2025 | 135.79 Mn |
| Dec 31, 2024 | 147.15 Mn |
| Sep 30, 2024 | 148.84 Mn |
| Jun 30, 2024 | 134.00 Mn |
| Mar 31, 2024 | 134.07 Mn |
| Dec 31, 2023 | 146.53 Mn |
| Sep 30, 2023 | 136.21 Mn |
| Jun 30, 2023 | 130.53 Mn |
| Mar 31, 2023 | 127.02 Mn |
| Dec 31, 2022 | 127.47 Mn |
| Sep 30, 2022 | 130.38 Mn |
| Jun 30, 2022 | 129.46 Mn |
| Mar 31, 2022 | 120.93 Mn |
| Dec 31, 2021 | 130.34 Mn |
| Sep 30, 2021 | 122.22 Mn |